"Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." PMC/PubMed Central , 2024
Retatrutide is Eli Lilly's triple agonist - one weekly injection that hits three receptors at once (GLP-1, GIP, glucagon)
Sermorelin boosts GH production for systemic benefits including body composition, sleep, and recovery
Most patients begin to notice results within two to four weeks, with the most significant changes appearing between weeks four and eight under a properly managed treatment plan
They can target specific parts of the immune system or have a broader effect on the entire body
Talarico C, Dattilo V, DAntona L, Barone A, Amodio N, Belviso S, et al